China is the world’s largest supplier of counterfeit pharmaceuticals and ingredients, and the source of 79% of all counterfeit drugs seized in the U.S. But enforcement-based solutions are complicated by the lack of cooperation from Beijing, according to a forthcoming paper in the Columbia Science and Technology Law Review.
U.S. policymakers have begun to focus on the security threats from Trinidad and Tobago, just off South America’s north coast. According to a new study, the island nation of 1.2 million is emerging as a narcotics shipping hub; and on a per capita basis, it has sent more foreign fighters to Iraq and Syria than anywhere else in the region.
President Rodrigo Duterte, whose deadly anti-drug campaign has faced intense international criticism, paused during a speech to tell a local police chief that it is his duty to “overcome the resistance” of any crime suspect. If he violently resists, Duterte said, “You are free to kill the idiots. That is my order to you.”
Some analysts are pushing for armed U.S. intervention in Mexico’s battle with drug traffickers to curb the opioid epidemic. But a security expert warns it would undercut more sensible strategies of decriminalization and treatment—and cost more lives.
Faouzi Jaber, a 61-year-old Ivorian citizen, pleaded guilty this week in a case involving smuggling arms and drugs to Colombia’s FARC group. But the undercover tactics by U.S. agents raise questions about future drug-war strategies in Colombia.
Despite a return to hardline drug-war rhetoric, the U.S. has weakened its partnership with other key allies in the war on drugs in the hemisphere, says a hemisphere expert. Exhibit A: the current policy muddle about how to stem Colombia’s increasing coca crop.
A survey conducted by the John Jay College Center on Terrorism found that only 38% of all respondents “expressed familiarity with the general idea that climate change could multiply global threats such as political violence or mass migrations, or act as a catalyst for conflict.”
Colombian President Juan Santos, who met President Trump at the White House last week, says the U.S. needs to change its hardline drug policy to focus on harm-reduction and the wider illicit activities conducted by transnational crime syndicates.